CarboplatinPaclitaxelAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungLung NeoplasmsOvarian NeoplasmsAntineoplastic Agents, PhytogenicDrug Administration ScheduleCisplatinAntineoplastic AgentsInfusions, IntravenousTreatment OutcomeEtoposidePlatinumIfosfamideArea Under CurveThrombocytopeniaCombined Modality TherapyDose-Response Relationship, DrugNeutropeniaMaximum Tolerated DoseDisease-Free SurvivalTaxoidsDeoxycytidineFallopian Tube NeoplasmsOrganoplatinum CompoundsDrug Resistance, NeoplasmSurvival AnalysisLeukopeniaNeoplasm StagingSurvival RateDoxorubicinHematologic DiseasesTopotecanNeoplasmsRetinal NeoplasmsVinblastinePeritoneal NeoplasmsThiotepaBreast NeoplasmsAmifostineTubulin ModulatorsCyclophosphamideDrug SynergismCarcinoma, Small CellBridged CompoundsRetinoblastomaCell Line, TumorDrug HypersensitivityEpothilonesNeoplasm Recurrence, LocalAntibodies, Monoclonal, HumanizedCarcinomaNeoplasms, Glandular and EpithelialEpirubicinIsocoumarinsNauseaPlatinum CompoundsFeasibility StudiesPeripheral Nervous System DiseasesDrug Screening Assays, AntitumorGerminomaDrug EvaluationTesticular Neoplasms